Crescentis Capital: Grant Date Set for MD's ESOPs

Crescentis Capital Ltd has determined October 8, 2026, as the grant date for Employee Stock Options (ESOPs) to its Managing Director, Mr. Subba Rao Veeravenkata Meka. This grant, under the CCL ESOS 2025, involves 5,00,000 stock options at an exercise price of ₹50 per option. The options will vest in two tranches: 50% on October 7, 2027, and the remaining 50% on October 7, 2028. This action follows shareholder approval at the 33rd AGM and is in compliance with SEBI regulations.